Jan 3, 2024 Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8, 2024 Learn More
Dec 19, 2023 Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation Learn More
Dec 12, 2023 Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform Learn More
Dec 5, 2023 Cellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit Europe Learn More